| First cycle degree courses | Second cycle degree courses | Single cycle degree courses |
| School of Medicine | ||
| PHARMACEUTICAL BIOTECHNOLOGIES | ||
Course unit
MOLECULAR AND EXPERIMENTAL PHARMACOLOGY
MEP5070476, A.A. 2018/19
Information concerning the students who enrolled in A.Y. 2018/19
MOLECULAR AND EXPERIMENTAL PHARMACOLOGY
MEP5070476, A.A. 2018/19
Information concerning the students who enrolled in A.Y. 2018/19
Information on the course unit
| Degree course |
Second cycle degree in PHARMACEUTICAL BIOTECHNOLOGIES ME2193, Degree course structure A.Y. 2015/16, A.Y. 2018/19 |
 bring this page with you |
|---|---|---|
| Number of ECTS credits allocated | 10.0 | |
| Type of assessment | Mark | |
| Course unit English denomination | MOLECULAR AND EXPERIMENTAL PHARMACOLOGY | |
| Department of reference | Department of Pharmaceutical and Pharmacological Sciences | |
| Mandatory attendance | Sì | |
| Language of instruction | English | |
| Branch | PADOVA | |
| Single Course unit | The Course unit can be attended under the option Single Course unit attendance | |
| Optional Course unit | The Course unit can be chosen as Optional Course unit |
Lecturers
| Teacher in charge | CHIARA BOLEGO | BIO/14 |
|---|
ECTS: details
| Type | Scientific-Disciplinary Sector | Credits allocated | |
|---|---|---|---|
| Educational activities in elective or integrative disciplines | BIO/14 | Pharmacology | 4.0 |
| Core courses | BIO/14 | Pharmacology | 6.0 |
Course unit organization
| Period | First semester |
|---|---|
| Year | 1st Year |
| Teaching method | frontal |
| Type of hours | Credits | Teaching hours |
Hours of Individual study |
Shifts |
|---|---|---|---|---|
| Laboratory | 2.0 | 30 | 20.0 | No turn |
| Lecture | 8.0 | 64 | 136.0 | No turn |
| Prerequisites: | Principles of Pharmacology |
| Target skills and knowledge: | Students will acquire advanced knowledge in pharmacology; particular attention will be paid to downstream pathways of receptor activation. These events are both responsible for key patho-physiological effects and targets for future drug development. Because a drug is useful only if it is effective in humans and many molecules fail during clinical development, students will pay particular attention to clinical trial analysis. Overall, students will understand how to identify new potential drug targets other than classical drug receptors.
The course also includes an experimental section, which provides the students the possibility to have a direct approach to research. At the end of the course students will be able to manipulate cell culture, perform independently basic experiments with up-to-date techniques, overcome common experimental problems and critically analyze the data obtained. |
| Examination methods: | Molecular Pharmacology section: test including both multiple choice and open questions. An "half-way" test will be performed.
Power point presentation and discussion. Experimental Pharmacology section: oral exam integrated by a written report. |
| Course unit contents: | -Analysis of molecular targets of drug action, which convey the messages of a drug to the body.
-Focus on the main intracellular signaling pathways activated by cell membrane receptors, in order to highlight potentially new molecular targets. -Basic knowledge of clinical pharmacology through the analysis of selected clinical trial outcomes - Application of experimental models for investigating the pharmacological profile of new drugs. |
| Planned learning activities and teaching methods: | Active-quiz |
| Additional notes about suggested reading: | Up-dated papers on specific topics |
| Textbooks (and optional supplementary readings) |
|
- Lecturing
- Active quizzes for Concept Verification Tests and class discussions
- Loading of files and pages (web pages, Moodle, ...)
- Students peer review
